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BACKGROUND. The National Cancer Institute (NCI) designates cancer centers as
regional centers of excellence in research and patient care. Although these centers
often advertise their superior outcomes, their relative performance has not been
examined empirically. In the current study, the authors assessed whether patients
at NCI cancer centers compared with patients at control hospitals had lower
mortality rates after major cancer surgery.
METHODS. Using the national Medicare database (1994 –1999), the authors as-
sessed surgical mortality and late survival rates for 63,860 elderly patients under-
going resection for lung, esophageal, gastric, pancreatic, bladder, or colon carci-
noma. For assessing performance, patients treated at the 51 NCI cancer centers
were compared with patients from 51 control hospitals with the highest volumes
for each procedure. Mortality rates (surgical and 5-year rates) were adjusted for
patient characteristics and residual differences in procedure volume.
RESULTS. NCI cancer centers had lower adjusted surgical mortality rates than
control hospitals for 4 of the 6 procedures, including colectomy (5.4% vs. 6.7%; P
 0.026), pulmonary resection (6.3% vs. 7.9%; P  0.010), gastrectomy (8.0% vs.
12.2%; P  0.001), and esophagectomy (7.9% vs. 10.9%; P  0.027). Nonsignificant
trends toward lower adjusted operative mortality rates at NCI cancer centers were
also observed for cystectomy and pancreatic resection. Among patients surviving
surgery, however, there were no important differences in subsequent 5-year mor-
tality rates between NCI cancer centers and control hospitals for any of the
procedures.
CONCLUSIONS. For many cancer procedures, patients undergoing surgery at NCI-
designated cancer centers had lower surgical mortality rates than those treated at
comparably high-volume hospitals, but similar long-term survival rates. Cancer
2005;103:435– 41. © 2004 American Cancer Society.
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Created in 1971 as a result of the National Cancer Act, the NationalCancer Institutes (NCI) cancer centers program was created to
establish regional centers of excellence in research and patient care.
Hospitals compete for cancer center designation and federal funding
on the basis of demonstrated excellence in three different areas:
research, cancer prevention, and clinical services. Hospitals selected
as comprehensive cancer centers (currently 38) meet the criteria for
all 3 areas. Clinical cancer centers (currently 15) are selected primarily
based on their clinical programs. Generic cancer centers (currently 8)
are primarily research institutions.
There are a number of reasons to believe that the NCI clinical and
comprehensive cancer centers might have better outcomes of cancer
surgery than other hospitals. NCI cancer centers are widely consid-
ered to be centers of excellence in cancer care because they are well
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staffed with specialists and tend to have high-proce-
dure volumes, both factors being associated with re-
duced surgical and late mortality rates after cancer
surgery.1– 4 Greater access to multidisciplinary consul-
tation (e.g., tumor boards) could also translate into
better treatment plans for patients at NCI cancer cen-
ters. In addition, NCI cancer centers may adopt new
and beneficial therapies earlier than other hospitals
and use more standard treatment protocols and clin-
ical pathways, and thus have less variation in pro-
cesses of care than other hospitals.
That NCI cancer centers have superior outcomes
is reinforced frequently by hospital advertising. To
date, however, the relative performance of NCI cancer
centers has not been examined empirically. For this
reason, we studied surgical mortality and long-term
survival rates among patients undergoing six cancer-
related procedures (i.e., cystectomy, colectomy, pul-
monary resection, pancreatic resection, gastrectomy,
and esophagectomy) based on data from the national
Medicare population. To assess the independent ef-
fect of cancer center designation, we compared out-
comes at 51 NCI cancer centers with the 51 other




These analyses are based on data from the Medicare
Provider Analysis and Review (MEDPAR) and the de-
nominator files from the Centers for Medicare and
Medicaid Services for the period 1994 –1999. These
files include hospital discharge abstracts for acute care
hospitalizations of all Medicare recipients covered by
the hospital care program (Part A). The MEDPAR file
only includes patients covered by fee for service ar-
rangements. Therefore, Medicare patients who were
enrolled in risk-bearing health maintenance organiza-
tions during this period (approximately 10% of Medi-
care enrollees) are not included in our analysis. We
excluded patients who were  65 or  99 years of age
from our analysis.
Six cancer procedures were chosen because of
their relative complexity and high surgical mortality
rates. We identified all discharges for these procedures
using appropriate procedure codes from the Interna-
tional Classification of Diseases ICD-9.5 To identify
only resections for cancer, we restricted our sample to
patients who had an accompanying cancer diagnosis
code that was related to the procedure of interest.
Relations between NCI designation status and the pri-
mary outcome measures were assessed separately for
all six procedures.
Hospital Selection
NCI-designated cancer centers are listed on the NCI
website (available from URL: www.nci.nih.gov). Links
to each center’s own website are also provided by the
NCI. These links were used to determine the zip code
and Medicare provider number of each NCI-desig-
nated cancer center and its affiliated hospitals. We
excluded from our analysis the generic (research-fo-
cused) cancer centers, as well as eight centers that did
not hold the NCI cancer center designation continu-
ously throughout our study period. Because the NCI
distinguishes between “comprehensive” and “clinical”
cancer centers based on the scope of research rather
than clinical activities, we combined the two types of
cancer centers for the purposes of the current analysis.
At NCI cancer centers where surgical care is delivered
in more than one hospital, we chose the highest vol-
ume hospital and any others exceeding the 90th per-
centile (averaged across the six procedures) for cancer
surgery volume. This process resulted in a total of 51
individual hospitals associated with 47 NCI cancer
centers.
Hospitals in the control group were selected ac-
cording to procedure-specific surgical volumes. As in
our previous studies,3,4 total surgical volumes were
determined by dividing the observed Medicare vol-
ume for each procedure during the study period by
the proportion of all patients undergoing the proce-
dure who were covered by Medicare, based on data
from the all-payer Nationwide In-Patient Sample.
Non-NCI cancer center hospitals were then rank-
ordered according to procedure volume and the 51
highest ranked hospitals for each procedure were des-
ignated control hospitals. Five hospitals were in the
control group for all 6 procedures, 7 hospitals for 5
procedures, 10 hospitals for 4 procedures, 22 hospitals
for 3 procedures, 34 hospitals for 2 procedures, and 67
hospitals for only 1 of the 6 procedures.
Analysis
The primary goal of the current analysis was to com-
pare NCI cancer centers and control hospitals with
respect to two outcome measures: surgical mortality
and late survival rates. The patient was used as the
unit of analysis, with cancer center designation as-
sessed at the hospital level. As in our previous stud-
ies,3,4 surgical mortality was defined as death before
hospital discharge or death within 30 days after the
index procedure. This definition was used because a
large number of surgical deaths occur before dis-
charge but  30 days after surgery. Long-term survival
was determined by following patients (using data in
the Medicare denominator files) from the date of the
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index surgical admission until death or the termina-
tion of the period of observation (i.e., December 31,
2001).
In assessing relations between cancer center des-
ignation and mortality, we adjusted for age (5 catego-
ries: 65– 69 years, 70 –74 years, 75–79 years, 80 – 84
years,  85 years), gender (male, female), and race
(non-black, black). We also adjusted for comorbid
conditions identified by ICD-9-CM code from all hos-
pitalizations within 6 months preceding the surgical
procedure6 and then used to calculate a Charlson
score, modified to exclude conditions reflecting primary
indication for surgery or surgical complications.7–10 We
adjusted for two variables measured at the patient’s zip
code level (i.e., mean social security income and rural or
urban residence).11, 12 For pulmonary resections, proce-
dure type (lobectomy vs. pneumonectomy) was also in-
cluded in the risk-adjustment models.
Chi-square tests were used to compare patient
characteristics between NCI cancer centers and con-
trol hospitals. We used multiple logistic regression to
compare surgical mortality rates and proportional
hazards models to compare long-term survival for
each procedure between NCI cancer centers and con-
trol hospitals. For each procedure, the validity of the
proportional hazards assumption was verified by vi-
sually inspecting the log-log survival plot. We used
robust variance estimates in both the logistic and pro-
portional hazards models to account for a lack of
independence between observations (i.e., clustering of
patients within hospitals). All analyses were per-
formed using Stata statistical software version 8 (Stata
Corporation, College Station, TX).13
RESULTS
Between 1994 and 1999, 27,021 patients underwent 1
of the 6 cancer procedures at an NCI cancer center
and 36,839 patients received 1 of these procedures at
a control hospital (Table 1). These patients represent
12.8% of the total number of Medicare patients (n
 500,705) undergoing these procedures during the
study period. Compared with control hospitals, NCI
cancer centers had lower volumes for colectomy but
similar volumes for the other procedures (Table 1).
There were few clinically important differences in
patient characteristics between NCI cancer centers
and control hospitals (Table 2). Patients treated at NCI
cancer centers had significantly higher Charlson co-
morbidity scores for four of the six procedures. Com-
pared with NCI cancer centers, control hospitals
treated significantly more patients  85 years for co-
lectomy and gastrectomy. NCI cancer centers treated
significantly more black patients for cystectomy, co-
lectomy, and pulmonary resection.
Differences in surgical mortality between NCI
cancer centers and control hospitals are shown in
Figure 1 and Table 3. In adjusted analyses (Fig. 1), NCI
cancer centers had significantly lower operative mor-
tality rates than control hospitals for 4 of the 6 proce-
dures, including colectomy (5.4% vs. 6.7%; P  0.026),
pulmonary resections (6.3% vs. 7.9%; P  0.010), gas-
trectomy (8.0% vs. 12.2%; P  0.001), and esophagec-
tomy (7.9% vs. 10.9%; P  0.027). Nonsignificant
trends toward lower adjusted surgical mortality at NCI
cancer centers were also observed for cystectomy and
pancreatic resection. The difference between NCI can-
cer centers and control hospitals was greatest for gas-
trectomy (adjusted odds ratio [OR]  0.63; 95% con-
fidence interval [95% CI], 0.50 – 0.79) and least with
pancreatic resection (adjusted OR  0.86; 95% CI,
0.61–1.21).
In contrast, differences in long-term survival rates
between NCI cancer centers and control hospitals
were considerably smaller (Fig. 2). Although differ-
ences were statistically significant for colectomy and
gastrectomy (Table 3), adjusted hazard ratios of mor-
tality rates at NCI cancer centers compared with con-
trol hospitals were generally close to 1, ranging from
TABLE 1
Distribution of Hospitals, Patients, and Procedure Volumes for NCI







No. of Medicare patients 2977 2566
Mean no. of procedures/yr  SD 18  16 16  7
Median no. of procedures/yr (range) 12 (1–82) 14 (10–42)
Colectomy
No. of Medicare patients 9615 19624
Mean no. of procedures/yr  SD 101  68 209  33
Median no. of procedures/yr (range) 92 (16–333) 197 (172–301)
Pulmonary resections
No. of Medicare patients 8360 9652
Procedure mix (% pneumonectomy) 13.3 12.2
Mean no. of procedures/yr  SD 55  62 63  14
Median no. of procedures/yr (range) 36 (2–313) 59 (48–117)
Pancreatic resection
No. of Medicare patients 2297 1575
Mean no. of procedures/yr  SD 18  23 12  5
Median no. of procedures/yr (range) 10 (1–136) 10 (7–27)
Gastrectomy
No. of Medicare patients 2599 2608
Mean no. of procedures/yr  SD 28  26 32  8
Median no. of procedures/yr (range) 21 (5–137) 30 (25–69)
Esophagectomy
No. of Medicare patients 1173 814
Mean no. of procedures/yr  SD 22  23 17  7
Median no. of procedures/yr (range) 13 (3–107) 15 (11–46)
NCI: National Cancer Institute; SD: standard deviation.
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0.88 (colectomy) to 1.05 (esophagectomy). Five-year
survival probabilities at NCI cancer centers and con-
trol hospitals differed by  4% (in absolute terms) for
each of the 6 procedures.
DISCUSSION
In the current study, we found that NCI cancer centers
had lower surgical mortality rates with some high-risk
cancer procedures than other comparable high-vol-
ume hospitals. Although to our knowledge the current
study is the first to examine surgical quality associated
with cancer center designation, numerous studies to
date have explored the effects of organizational char-
acteristics and other structural variables. In addition
to procedure volume,3,14 –16 hospital attributes that
have been linked to lower surgical mortality rates after
surgery include participation in clinical trials, inten-
sivist staffing of intensive care units, and high nurse-
to-bed ratios.17–20 At the surgeon level, both procedure
volume and subspecialty training appear to have in-
dependent effects on surgical mortality.4,21–23
There are at least two potential explanations for
lower surgical mortality rates at NCI cancer centers.
First, these centers could be treating lower-risk pa-
tients than other high-volume hospitals. Although we
did not identify important differences with respect to
patient age, race, and comorbidity burden, Medicare
claims are limited in their ability to capture illness
severity for purposes of risk adjustment.8,24 –27 We can-
not rule out differences in other patient characteristics
potentially related to surgical mortality. For example,
patients traveling to well known centers of excellence
may be more fit, affluent, or healthy in ways that are
not measurable with the use of data from hospital
claims.28 However, these same factors would, presum-
ably, confer advantages for NCI cancer centers with
respect to late mortality, which we did not observe.
Thus, it seems unlikely that our findings can be attrib-
uted entirely to selection bias.
Alternatively, lower surgical mortality rates at NCI
cancer centers could reflect higher-quality surgical
care. If so, we can only speculate on potential reasons
for their better outcomes. First, patients undergoing
high-risk surgery at NCI cancer centers may be se-
lected more carefully. For example, patients at NCI
cancer centers may be more likely to be considered in
multidisciplinary conferences (tumor boards) or to
receive consultations with nonsurgical specialists pre-
operatively. Patients at cancer centers may also un-
dergo more sophisticated preoperative imaging tests.
Better processes related to patient selection could
identify patients better managed without surgery or
help surgeons anticipate potential complications. Sec-
ond, surgeons at NCI cancer centers may be more
specialized than their counterparts at other high-vol-
ume hospitals. Greater experience with specific pro-
cedures could translate to better clinical decision-
making or greater technical proficiency. Many of these
hypotheses could be tested directly by more detailed
analysis of outpatient and physician claims, but not
with the inpatient files (hospital discharge abstracts)
available for the current study.
TABLE 2
Medicare Cancer Surgery Patient Characteristics at NCI Cancer








Age  85 yrs (%) 3.8 3.1 0.164
Gender (% female) 18.2 18.9 0.528
Race (% black) 4.3 3.0 0.008
Charlson comorbidity score (%  3) 46.2 36.6  0.001
From urban area (%) 70.5 70.4 0.929
From low income zip code (%) 19.8 19.9 0.958
Colectomy
Age  85 yrs (%) 13.4 16.2  0.001
Gender (% female) 54.0 54.4 0.489
Race (% black) 14.1 6.1  0.001
Charlson comorbidity score (%  3) 49.2 46.2  0.001
From urban area (%) 79.8 87.4  0.001
From low income zip code (%) 22.2 19.1  0.001
Pulmonary resection
Age  85 yrs (%) 1.7 1.5 0.262
Gender (% female) 42.9 42.1 0.274
Race (% black) 5.9 4.7  0.001
Charlson comorbidity score (%  3) 43.8 36.7  0.001
From urban area (%) 69.8 65.1  0.001
From low income zip code (%) 18.3 23.3  0.001
Pancreatic resection
Age  85 yrs (%) 1.9 1.9 0.941
Gender (% female) 48.5 46.3 0.167
Race (% black) 5.7 5.2 0.579
Charlson comorbidity score (%  3) 65.0 54.5  0.001
From urban area (%) 71.0 73.6 0.081
From low income zip code (%) 18.6 19.9 0.335
Gastrectomy
Age  85 yrs (%) 7.0 10.3  0.001
Gender (% female) 35.5 38.7 0.018
Race (% black) 10.6 12.3 0.046
Charlson comorbidity score (%  3) 63.8 62.3 0.267
From urban area (%) 74.7 81.1  0.001
From low income zip code (%) 19.4 22.1 0.015
Esophagectomy
Age  85 yrs (%) 1.4 1.6 0.670
Gender (% female) 25.2 23.2 0.324
Race (% black) 6.2 6.1 0.870
Charlson comorbidity score (%  3) 43.4 41.0 0.295
From urban area (%) 63.9 68.1 0.052
From low income zip code (%) 17.9 20.6 0.149
NCI: National Cancer Institute.
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To our surprise, treatment at NCI cancer centers
did not confer important advantages with regard to
long-term survival. We had hypothesized that more
specialized surgeons at cancer centers might achieve
more complete surgical resections or that cancer cen-
ters would be first to implement beneficial new adju-
vant therapies. We also hypothesized that patients at
cancer centers would be more likely to be followed
according to standardized surveillance protocols after
surgery, which could detect some recurrent cancers in
FIGURE 1. Adjusted surgical mortality rates for patients undergoing surgery at National Cancer Institute cancer centers compared with control hospitals.
TABLE 3
Observed and Adjusted Outcomes of Cancer Surgery at NCI Cancer Centers Compared with Control Hospitals
Procedures





Cystectomy 2.7% 3.6% 0.74 (0.54–1.02) 0.80 (0.58–1.09)
Colectomy 4.7% 5.5% 0.86 (0.73–1.01) 0.80 (0.65–0.98)
Pulmonary resection 4.4% 5.6% 0.76 (0.62–0.94) 0.78 (0.64–0.94)
Pancreatic resection 4.6% 7.1% 0.64 (0.44–0.93) 0.86 (0.61–1.21)
Gastrectomy 6.5% 10.5% 0.59 (0.46–0.77) 0.63 (0.50–0.79)
Esophagectomy 7.7% 12.3% 0.59 (0.43–0.83) 0.70 (0.51–0.97)
Procedure
5-year mortality rates in surgery





Cystectomy 60% 61% 0.98 (0.91–1.07) 0.94 (0.85–1.03)
Colectomy 49% 50% 0.97 (0.91–1.03) 0.88 (0.81–0.96)
Pulmonary resection 57% 59% 0.95 (0.89–1.02) 0.93 (0.86–1.00)
Pancreatic resection 76% 76% 0.96 (0.87–1.06) 0.97 (0.87–1.08)
Gastrectomy 68% 71% 0.92 (0.83–1.02) 0.91 (0.83–0.99)
Esophagectomy 72% 68% 1.04 (0.91–1.19) 1.05 (0.92–1.20)
NCI: National Cancer Institute; CI: confidence interval.
a Adjusted for patient characteristics and residual procedure volume differences.
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the early stages when treatment can lead to disease
remission. Although our null findings related to late
survival do not support these hypotheses, our results
should be interpreted carefully. With the inpatient
hospital data available for these analyses, we could not
determine whether patients continued to receive fol-
low-up care at the same center at which the surgery
was performed or at community hospitals closer to
home. Thus, our study provides stronger inferences
regarding the quality of the surgical experience than
the quality of subsequent surveillance or adjuvant
therapy.
Our study has other limitations. Because our anal-
ysis was restricted to Medicare patients age  65 years,
our findings may not be generalizable to younger pa-
tients. However, it is worth noting that Medicare pa-
tients account for greater than one-half of patients
undergoing major cancer resections in the U.S. and an
even greater majority of patients who die after sur-
gery.29 In addition, Medicare data are not perfect for
identifying the presence or absence of cancer. How-
ever, we focused exclusively on cancers involving ma-
jor, inpatient procedures, for which claims data tend
to be more highly reliable.30 Nonetheless, our surgical
cohort no doubt included some patients without can-
cer and excluded some patients with cancer. To the
extent that this error is random, the misclassification
of patients with cancer would bias our results toward
the null hypothesis (i.e., no difference between the
NCI cancer centers and other hospitals).
The results of the current study suggest that NCI
cancer center designation should be weighted less
heavily than other factors in a patient’s deciding
where to undergo major cancer surgery. Although
these facilities have moderately lower surgical mortal-
ity rates with several procedures, their long-term sur-
vival rates are comparable to those of other high-
volume hospitals. These findings may be reassuring
FIGURE 2. Long-term survival for pa-
tients undergoing surgery at National
Cancer Institute cancer centers com-
pared with control hospitals.
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for many patients residing outside the Northeast, Mid-
west, and Southern California, where the majority of
NCI cancer centers are located. The best evidence to
date suggests a number of other factors to consider
when deciding where to undergo major cancer surgery
and by whom the surgery should be performed. Pa-
tients will optimize their odds after cancer surgery by
selecting high-volume hospitals. They will also fare
better with high-volume surgeons with subspecialty
training. Although patients can generally expect such
providers at NCI cancer centers, most patients also
should be able to find them at high-volume centers
closer to home.
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